Alpine Immune Sciences Inc (ALPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,376 | 126,625 | 24,360 | 34,889 | 67,907 |
| Marketable Securities | 224,265 | 122,237 | 143,500 | 136,980 | 94,396 |
| Receivables | 392 | 382 | 1,317 | 132 | 25,000 |
| TOTAL | $240,993 | $253,239 | $172,289 | $176,096 | $192,013 |
| Non-Current Assets | |||||
| PPE Net | 1,584 | 1,608 | 1,596 | 1,728 | 1,716 |
| Investments And Advances | 35,481 | 28,016 | 33,041 | 46,948 | 52,866 |
| Other Non-Current Assets | 8,628 | 8,736 | 8,900 | 9,166 | 9,305 |
| TOTAL | $45,693 | $38,360 | $43,537 | $57,842 | $63,887 |
| Total Assets | $286,686 | $291,599 | $215,826 | $233,938 | $255,900 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,380 | 4,547 | 4,682 | 4,652 | 4,622 |
| Accounts payable and accrued liabilities | 4,286 | 3,240 | 1,812 | 1,903 | 3,349 |
| Accrued Expenses | 14,003 | 13,744 | 12,525 | 9,203 | 9,417 |
| TOTAL | $57,996 | $68,459 | $62,618 | $68,165 | $69,778 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 1,025 | 2,206 | 3,380 |
| Deferred Revenues | 35,571 | 46,210 | 42,917 | 51,760 | 51,773 |
| Other Non-Current Liabilities | 10,085 | 10,328 | 10,564 | 10,794 | 11,009 |
| TOTAL | $49,270 | $41,131 | $53,672 | $50,346 | $65,219 |
| Total Liabilities | $107,266 | $109,590 | $116,290 | $118,511 | $134,997 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 47,757 | 45,914 | 30,401 | 30,328 | 30,294 |
| Common Shares | 46 | 44 | 30 | 30 | 30 |
| Retained earnings | -223,961 | -205,097 | -191,824 | -173,726 | -166,199 |
| Other shareholders' equity | -1,121 | -1,669 | -1,369 | -1,061 | -273 |
| TOTAL | $179,420 | $182,009 | $99,536 | $115,427 | $120,903 |
| Total Liabilities And Equity | $286,686 | $291,599 | $215,826 | $233,938 | $255,900 |